Epiphany Biosciences announces positive results from phase IIb trial in shingles
EPB-348 is a potent inhibitor of herpes viruses, including the varicella zoster and Epstein-Barr viruses licensed from the Swedish biotech company Medivir AB.
If you enjoyed this post, make sure you subscribe to my RSS feed!
